Besides them, we counted 1 critical employee of this fund in our database.
The high activity for fund was in 2018. The common things for fund are deals in the range of 10 - 50 millions dollars. The fund is constantly included in less than 2 investment rounds annually. The increased amount of exits for fund were in 2017.
The standard case for the fund is to invest in rounds with 3 partakers. Despite the CMS Medical Venture Investment, startups are often financed by Juno Capital Partners, Downing Ventures, Downing LLP. The meaningful sponsors for the fund in investment in the same round are Newton Biocapital, Mirae Asset Global Investments, CapDecisif. In the next rounds fund is usually obtained by Newton Biocapital, Go Capital, CapDecisif.
The fund has no exact preference in some founders of portfolio startups. Besides, a startup needs to be aged 11-15 years to get the investment from the fund. Among the various public portfolio startups of the fund, we may underline Acticor Biotech, Destiny Pharma We can highlight the next thriving fund investment areas, such as Health Care, Biotechnology.
Related Funds
Fund Name | Location |
Arcturus Capital | California, Pasadena, United States |
Blue Mountain | California, San Diego, United States |
CIBA Centre for Incubation and Business Acceleration | - |
DC Investment Partners | Mclean, United States, Virginia |
Desjardins Group | Canada, Quebec, Quebec |
East Gate Capital Management | California, Los Altos, United States |
Green Bank | Houston, Texas, United States |
Hook-Up Communications | - |
Janus Henderson Investors | England, London, United Kingdom |
Narra Venture Capital | Manila, Philippines |
Pets.com | California, Pasadena, United States |
Planet 9 Capital | - |
Pritzker Foundation | - |
Pusi Capital | - |
Synergie Finance | Dorset, Gillingham, United Kingdom |
Teak Capital | Kuala Lumpur, Malaysia |
Tech Square Ventures | Atlanta, Georgia, United States |
Warner Bros. | Burbank, California, United States |
Woodforest National Bank | Texas, The Woodlands, United States |
Woodside Fund | California, Redwood Shores, United States |
Notable deals
Company | Industry | Round Size | Date | Investors | Location |
Acticor Biotech | $8M | 06 Nov 2019 | Ile-de-France | ||
Acticor Biotech | $18M | 17 Oct 2018 | Ile-de-France |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Latest deals
Company | Industry | Round Size | Date | Investors | Location |
Acticor Biotech | $8M | 06 Nov 2019 | Ile-de-France | ||
Acticor Biotech | $18M | 17 Oct 2018 | Ile-de-France |